I et klinisk forsøg med raske personer øgede en potent CYP2D6- hæmmer (quinidin) aripiprazols AUC med 107%, mens Cmax var uforandret.
In a clinical trial in healthy subjects, a potent inhibitor of CYP2D6 (quinidine) increased aripiprazole AUC by 107%, while Cmax was unchanged.